Spirulina Platensis in the Management of Type 2 Diabetes: A Systematic Review

Abstract

Background: Diabetes, characterized by insufficient insulin production or ineffective insulin utilisation, poses serious health risks if left unmanaged, including hypertension, hyperlipidemia, and organ damage. Spirulina platensis, a blue-green microalgae, has garnered attention for its potential in managing metabolic disorders like diabetes. However, its impact on blood sugar control remains inadequately understood. Consequently, this review aims to explore the efficacy of Spirulina platensis in managing type 2 diabetes mellitus.
Methods: A systematic search of PubMed, Embase, and Cochrane databases was done to identify original research articles that were published within the last 25 years.
Results: A total of 65 articles were retrieved. Upon screening, 56 articles were excluded for not meeting inclusion criteria. The remaining 9 articles revealed promising outcomes associated with Spirulina platensis supplementation, including reductions in fasting blood sugar (FBS), postprandial blood sugar (PPBS), glycated hemoglobin (HbA1C), total cholesterol, triglycerides, and malondialdehyde (MDA) levels.
Conclusion: Spirulina platensis demonstrates potential in improving key health indicators among type 2 diabetic patients. Health practitioners should consider recommending its adjunct use alongside glucose-regulating medication for enhanced diabetes management.